Kyung Eob Choi

956 total citations
26 papers, 775 citations indexed

About

Kyung Eob Choi is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Kyung Eob Choi has authored 26 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Kyung Eob Choi's work include Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (5 papers) and Acute Myeloid Leukemia Research (3 papers). Kyung Eob Choi is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (5 papers) and Acute Myeloid Leukemia Research (3 papers). Kyung Eob Choi collaborates with scholars based in United States, South Korea and United Kingdom. Kyung Eob Choi's co-authors include Richard L. Schilsky, Joseph A. Sinkule, Elizabeth K. Senekjian, Nicholas J. Vogelzang, Stephen P. Ackland, Mark J. Ratain, Richard A. Larson, William R. Crom, William E. Evans and Ho Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Analytical Biochemistry.

In The Last Decade

Kyung Eob Choi

26 papers receiving 750 citations

Peers

Kyung Eob Choi
Sachin Shah United States
R J Spooner United Kingdom
E. Boven Netherlands
An K. Stroobants Netherlands
V. Girre France
Laura Boehnke Michaud United States
Claire Siemes Netherlands
Melanie P. Hoenig United States
Sachin Shah United States
Kyung Eob Choi
Citations per year, relative to Kyung Eob Choi Kyung Eob Choi (= 1×) peers Sachin Shah

Countries citing papers authored by Kyung Eob Choi

Since Specialization
Citations

This map shows the geographic impact of Kyung Eob Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung Eob Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung Eob Choi more than expected).

Fields of papers citing papers by Kyung Eob Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung Eob Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung Eob Choi. The network helps show where Kyung Eob Choi may publish in the future.

Co-authorship network of co-authors of Kyung Eob Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung Eob Choi. A scholar is included among the top collaborators of Kyung Eob Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung Eob Choi. Kyung Eob Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Kyung Eob, et al.. (2013). Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertension Research. 36(11). 1000–1005. 83 indexed citations
2.
Sohn, Hyun Soon, et al.. (2012). Prescribing Patterns of Antivirals for Chronic Hepatitis B. Korean Journal of Clinical Pharmacy. 22(1). 81–86. 2 indexed citations
3.
Lee, Young Sook, et al.. (2010). Development of Drug Utilization Review Guidelines for Therapeutic Duplication of Antipyretics, Analgesics, and Anti-inflammatory Drugs Registered in Korea. Korean Journal of Clinical Pharmacy. 20(3). 213–220. 1 indexed citations
4.
Sohn, Hyun Soon, et al.. (2010). Analysis of Frequent Therapeutic Duplication Drug Classes Based on National Health Insurance Claimed Data in Korea. Korean Journal of Clinical Pharmacy. 20(3). 262–267. 1 indexed citations
5.
Choi, Kyung Eob, et al.. (2006). The Fractures of Humerus Shaft and Medial Epicondyle by Arm Wrestling. Journal of the Korean Fracture Society. 19(4). 437–437. 6 indexed citations
6.
Kang, Eun Hee, Kyung Eob Choi, & Sukhyang Lee. (2003). Effects of Influenza Vaccination on Respiratory Diseases. Korean Journal of Clinical Pharmacy. 13(1). 5–12. 1 indexed citations
7.
Ko, Young Hyeh, et al.. (2001). Comparative genomic hybridization study of nasal‐type NK/T‐cell lymphoma. Cytometry. 46(2). 85–91. 49 indexed citations
8.
Schilsky, Richard L., et al.. (1990). Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer.. Journal of Clinical Oncology. 8(12). 2054–2061. 41 indexed citations
9.
Kaminer, Lynne, et al.. (1990). Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia. Cancer. 65(12). 2619–2623. 9 indexed citations
10.
Ackland, Stephen P., et al.. (1989). Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin. Clinical Pharmacology & Therapeutics. 45(4). 340–347. 76 indexed citations
11.
Schilsky, Richard L., et al.. (1989). Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing. Cancer. 63(S6). 1018–1021. 32 indexed citations
12.
Ratain, Mark J., et al.. (1989). Adaptive control of etoposide administration: Impact of interpatient pharmacodynamic variability. Clinical Pharmacology & Therapeutics. 45(3). 226–233. 75 indexed citations
13.
Vokes, Everett E., Kyung Eob Choi, Richard L. Schilsky, et al.. (1988). Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.. Journal of Clinical Oncology. 6(4). 618–626. 60 indexed citations
14.
Choi, Kyung Eob & Richard L. Schilsky. (1988). Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography. Analytical Biochemistry. 168(2). 398–404. 38 indexed citations
15.
Ackland, Stephen P., Kyung Eob Choi, Mark J. Ratain, et al.. (1988). Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamide.. Journal of Clinical Oncology. 6(7). 1192–1196. 32 indexed citations
16.
Teresi, M., William R. Crom, Kyung Eob Choi, Joseph Mirro, & William E. Evans. (1987). Methotrexate bioavailability after oral and intramuscular administration in children. The Journal of Pediatrics. 110(5). 788–792. 61 indexed citations
17.
Choi, Kyung Eob, et al.. (1987). High-performance liquid chromatographic assay for mitoxantrone in plasma using electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 420(1). 81–88. 26 indexed citations
18.
Larson, Richard A., et al.. (1987). A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.. Journal of Clinical Oncology. 5(3). 391–397. 40 indexed citations
19.
Bennett, Charles L., Joseph A. Sinkule, Richard L. Schilsky, Elizabeth K. Senekjian, & Kyung Eob Choi. (1987). Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.. PubMed. 47(7). 1952–6. 72 indexed citations
20.
Choi, Kyung Eob, Joseph A. Sinkule, William R. Crom, Elizabeth I. Thompson, & William E. Evans. (1985). High-performance liquid chromatographic assay of mitomycin in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 345(1). 197–202. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026